Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Drug Information » FDA Approved Drugs » 1997
Medical Areas: Gastroenterology | Family Medicine

View By:YearCompanyConditionsTherapeutic AreasDrug Names

Asacol (mesalamine)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Procter & Gamble
Approval Status: Approved August 1997
Treatment Area: ulcerative colitits

General Information

Asacol (mesalamine) was approved by the Food and Drug Administration in August 1997. Asacol tablets are indicated for the treatment of mildly to moderately active ulcerative colitis and for the maintenance of remission of ulcerative colitis.

Side Effects

Side effects include headaches, abdominal pain, eructation, and nausea.